OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Resist antibiotic therapy

Resist antibiotic therapy


Antibiotic resistance is a form of drug resistance where bacteria are able to survive after exposure to one or more antibiotics. Bacteria that are resistant to multiple antibiotics are considered multidrug resistant (MDR) or, more colloquially, superbugs.
Commons types of drug resistance bacteria include MRSA methicillin-resistant Staphylococcus aureus, VRSA (vancomycin-resistant S. aureus), ESBL (extended spectrum beta-lactamase), VRE (vancomycin-resistant Enterococcus) and MRAB (multidrug-resistant A. baumannii). While mostly hospital acquired some are being transmitted in the community. In the simplest cases, drug-resistant organisms may have acquired resistance to first-line antibiotics, thereby necessitating the use of second-line agents. Typically, a first-line agent is selected on the basis of several factors including safety, availability, and cost; a second-line agent is usually broader in spectrum, has a less favourable risk-benefit profile, and is more expensive or, in dire circumstances, may be locally unavailable. In the case of some MDR pathogens, resistance to second- and even third-line antibiotics is, thus, sequentially acquired, a case quintessentially illustrated by Staphylococcus aureus in some health care settings. Some pathogens, such as Pseudomonas aeruginosa, also possess a high level of resistance.
It may take the form of a spontaneous or induced genetic mutation, or the acquisition of resistance genes from other bacterial species by horizontal gene transfer via conjugation, transduction, or transformation. Many antibiotic resistance genes reside on transmissible plasmids, facilitating their transfer. Exposure to an antibiotic naturally selects for the survival of the organisms with the genes for resistance. In this way, a gene for antibiotic resistance may readily spread through an ecosystem of bacteria. Once a bacterium becomes resistant to an antibiotic, it is unable to return to its previous state of vulnerability. Resistance will be passed on to all of the daughter cells of the resistant microbe. Antibiotic-resistance plasmids frequently contain genes conferring resistance to several different antibiotics. This is not the case for Mycobacterium tuberculosis, the bacteria that causes tuberculosis, since evidence is lacking for whether these bacteria have plasmids. Also M. tuberculosis lack the opportunity to interact with other bacteria in order to share plasmids.
Genes for resistance to antibiotics, like the antibiotics themselves, are ancient. However, the increasing rates of antibiotic-resistant bacterial infections seen in clinical practice stems from antibiotic use both within human medicine and veterinary medicine. Any use of antibiotics can increase selective pressure in a population of bacteria to allow the resistant bacteria to thrive and the susceptible bacteria to die off. As resistance towards antibiotics becomes more common, a greater need for alternative treatments arises. However, despite a push for new antibiotic therapies, there has been a continued decline in the number of newly approved drugs. Antibiotic resistance therefore poses a significant problem. Antibiotic resistance is a serious and growing problem. A World Health Organization report released April, 2014 states, "this serious threat is no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone, of any age, in any country. Antibiotic resistance–when bacteria change so antibiotics no longer work in people who need them to treat infections–is now a major threat to public health."

OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosted 6 open access articles Open Access articles, 40 Scientific conference Proceedings, 8 national symposiums and on Key word in Global Events page. Global Events of Conference series make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions of OMICS International Conferences.

Importance and scope:

In general, clinical studies are designed to add to medical knowledge related to the treatment, diagnosis, and prevention of diseases or conditions. Some common reasons for conducting clinical studies include: Evaluating one or more interventions (for example, drugs, medical devices, approaches to surgery or radiation therapy) for treating a disease, syndrome, or condition Finding ways to prevent the initial development or recurrence of a disease or condition. These can include medicines, vaccines, or lifestyle changes, among other approaches.Evaluating one or more interventions aimed at identifying or diagnosing a particular disease or condition,Examining methods for identifying a condition or the risk factors for that condition.

Market Analysis:

New technologies and the outsourcing of antibiotics to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014. The report provides an overview of clinical development phases, the regulatory issues involved, and the factors influencing clinical trial costs. An overview is provided of new technologies that will be affecting the clinical trial process in the near future.

Associations

  • British society of immunology
  • Clinical immunology society
  • Indian immunology society
  • Canadian society for immunology
  • Society for mucosal immunology
  • European society of clinical microbiology and infectious diseases (escmid)
  • European molecular biology organization
  • European mycological association
  • European society for clinical virology
  • Swedish society for microbiology,
  • Swedish society of infectious diseases
  • Swedish society of medical microbiology
  • Swiss society for infectious disease
  • Society for general microbiology
  • Italian association for clinical microbiology
  • International Union of Microbiological Societies
  • American Society for Microbiology
  • Society for General Microbiology
  • World Society for Microbiology
  • Society for Applied Microbiology
  • International Committee on Food Microbiology and Hygiene
  • Canadian Society of Microbiologist
  • International Society for Antiviral Research (ISAR)
  • International Society for Microbial Ecology (ISME)

Companies:

  • DOW
  • Freeslate
  • Agilent Technologies
  • BASF
  • CAPSUGEL
  • chemspeed Technologies
  • DRGT
  • LTS
  • LUCIDEON
  • NETZSCH
  • Octo plus
  • PHASTquality services
  • PSE 
  • Quotient Clinical
  • ShinEtsu
  • Sotax
  • Freund Pharmatec Ltd.
  • Laboratoria Smeets
  • Quay Pharma
  • IPSEN
  • novo nordisk
  • Crucell Vaccines Inc.
  • Medimmune
  • Sanofi
  • BAYER
  • REGENERON
  • EMD Serono
  • TEVA Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim
  • Celgene
  • AKRIKHIN arno therapeutics
  • TROPHOS
  • CLARIANT
  • Pharmaceutical-Technology.com pharmTech

Best Confrences:

 

 

This page will be updated regularly.

This page was last updated on 09th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising